Cosmos Health Inc. Share Price

Equities

COSM

US2214133058

Pharmaceuticals

Market Closed - Nasdaq 02:00:00 27/04/2024 am IST 5-day change 1st Jan Change
0.65 USD +25.75% Intraday chart for Cosmos Health Inc. +34.35% -53.90%
Sales 2023 * 51.29M 4.27B Sales 2024 * 63.98M 5.33B Capitalization 10.95M 913M
Net income 2023 * -7M -583M Net income 2024 * -8M -667M EV / Sales 2023 * 0.21 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 0.17 x
P/E ratio 2023 *
-1.02 x
P/E ratio 2024 *
-1.38 x
Employees 102
Yield 2023 *
-
Yield 2024 *
-
Free-Float 86.51%
More Fundamentals * Assessed data
Dynamic Chart
1 day+25.75%
1 week+34.35%
Current month-8.45%
1 month-8.45%
3 months-38.10%
6 months-35.00%
Current year-53.90%
More quotes
1 week
0.49
Extreme 0.49
0.69
1 month
0.47
Extreme 0.4677
0.73
Current year
0.47
Extreme 0.4677
1.50
1 year
0.47
Extreme 0.4677
4.00
3 years
0.47
Extreme 0.4677
194.25
5 years
0.47
Extreme 0.4677
225.00
10 years
0.47
Extreme 0.4677
322.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 26/16/26
Director of Finance/CFO 42 11/20/11
Chief Operating Officer 55 01/23/01
Members of the board TitleAgeSince
Director/Board Member 64 28/22/28
Director/Board Member 57 13/14/13
Chief Executive Officer 58 26/16/26
More insiders
Date Price Change Volume
26/24/26 0.65 +25.75% 473,548
25/24/25 0.5169 +1.35% 52,286
24/24/24 0.51 -3.59% 80,497
23/24/23 0.529 +7.74% 155,162
22/24/22 0.491 +1.49% 135,439

Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST

More quotes
Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.65 USD
Average target price
4 USD
Spread / Average Target
+515.38%
Consensus